LYKA LABS LTD. - 500259 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ipca Laboratories Ltd LYKA LABS LTD. - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of Share Certificates under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015. LYKA LABS LTD. - 500259 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 03, 2022 for Kunal Narendra gandhi LYKA LABS LTD. - 500259 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 03, 2022 for Kunal Narendra gandhi LYKA LABS LTD. - 500259 - Updates on Open Offer
Arihant Capital Markets Ltd ("Manager to the Offer") has submitted to BSE a copy of Offer Opening Public Announcement for the attention of the Equity Shareholders of Lyka Labs Ltd ("Target Company"). LYKA LABS LTD. - 500259 - Outcome Of The Board Meeting
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held on 20th January, 2022 considered and approved; 1. Un-audited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2021 (enclosed). LYKA LABS LTD. - 500259 - Board Meeting Outcome for Outcome Of The Board Meeting
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held on 20th January, 2022 considered and approved; 1. Un-audited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December, 2021 (enclosed). LYKA LABS LTD. - 500259 - Updates on Open Offer
Arihant Capital Markets Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement cum Corrigendum to Detailed Public Statement (DPS) for the attention of the Equity Shareholders of Lyka Labs Ltd ("Target Company"). LYKA LABS LTD. - 500259 - Updates on Open Offer
Arihant Capital Markets Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendation of Committee of Independent Directors (IDC) on the Open Offer to the Equity Shareholders of Lyka Labs Ltd ("Target Company").
